Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
The system boasts features that help streamline processes in the SPD and OR and reduce the possibility of wet sets.
Machine learning approach to systems biology combined with ligand discovery platform
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries
The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed
The total cost of the project is estimated at Rs 30 crore
Subscribe To Our Newsletter & Stay Updated
